Tele: 561.316.3330
Breaking Medical Device News

Tuesday, October 19, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR

April 16, 2021

St. Luke’s has introduced its new COVID Recovery Clinic, a program dedicated to the treatment of post-COVID-19 patients with lingering symptoms.

St. Luke’s recognizes the prevalence of “long COVID” symptoms and the need to care for patients afflicted by these symptoms appropriately.  Incorporating the expertise of a half dozen different kinds of medical specialists, the program promises a coordinated, multidisciplinary approach to Post-Acute Sequelae of COVID, known as PASC.  Participants will benefit from specialized evaluation and a personalized treatment plan.

“Many people recovering from COVID continue to have long-lasting symptoms that impact their day-to-day lives. St. Luke’s is committed to helping these patients get access to the most appropriate care so they can find relief,” said St. Luke’s Senior Regional Medical Director Dennis McGorry, MD, who is spearheading the program.

Nationally, PASC of varying severity is being reported in up to 30% of adults and children following COVID infection.

Most typical COVID cases resolve in four weeks, explained Jeffrey Jahre, MD, St. Luke’s Vice President of Medical & Academic Affairs and Section Chief Emeritus of Infectious Diseases.  But for some, the symptoms aren’t going away. “Patients are going to their doctor, asking, ‘What’s wrong with me?’ In many cases, people are not getting the appropriate care.”

The most common after-effects these patients, or “long haulers,” experience include extreme fatigue, memory impairment, known as “brain fog,” anxiety and depression, breathing difficulty and heart muscle irregularities or irregular heartbeats.

Patients with persistent symptoms beyond four weeks are advised to go to their St. Luke’s primary care physician, who will be able to evaluate them and may refer them to the COVID Recovery Clinic for further treatment by appropriate medical specialists.

Depending on a patient’s specific symptoms and their severity, treatment can include cognitive and memory retraining, physical and occupational therapy, medication and group therapy for behavioral health issues as well as other interventions to address neurologic, pulmonary and cardiac problems.

St. Luke’s has taken steps to help providers manage PASC, such as building a “smart set” algorithm into the electronic medical record system. The smart set guides physicians on ordering tests and imaging scans based on patients’ symptoms.

While some COVID after-effects may be mild, McGorry said, “The key is not missing something serious like a pulmonary embolism or cardiomyopathy (heart muscle issue) in these patients.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Adam S. Epstein New CEO of AliMed, Inc.

In his prior role as Chief Commercial Officer, Epstein directed all customer-facing, demand generation and product development activities. Under his new leadership, AliMed will continue to build a robust portfolio of contracted positions with major, national GPO’s, IDN’s, and Distribution partners to drive sales growth.

Tony Collins Appointed CFO of Xenter

“Xenter is building a platform for medical innovations that is transformational. The only way we can achieve our objectives is if we have great leaders like Tony Collins leading our company,” stated Richard J. Linder, Founder, Chairman & CEO of Xenter, Inc. “Tony brings incredible depth and experience to his new role as Chief Financial Officer.

Scott Sexton Appointed President at FIGUR8

"Scott brings to FIGUR8 30 years of workers' compensation, casualty, disability, and commercial health experience, most recently serving as a market leader for CorVel's national carrier practice sales team," said Nan-Wei Gong, CEO, and co-founder of FIGUR8.

Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced...

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

By using this website you agree to accept Medical Device News Magazine Privacy Policy